Modulation of T-cell responses to alloantigens by TR6/DcR3

Journal of Clinical Investigation

Volumn 107, Issue 11, 2001, Pages 1459-1468

  Zhang, Jun ^a   Salcedo, Theodora W ^a   Wan, Xiaochun ^b   Ullrich, Stephen ^a   Hu, Bugen ^a   Gregorio, Theresa ^a   Feng, Ping ^a   Qi, Shijie ^b   Chen, Huifang ^b   Cho, Yun Hee ^a   Li, Yuling ^a   Moore, Paul A ^a   Wu, Jiangping ^b,c,d  

^a GLAXOSMITHKLINE   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; FAS LIGAND; LYMPHOKINE; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; IMMUNOREGULATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034983086     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12159     Document Type: Article

References (33)

1. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
2. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster
3. A newly identified member of tumor necrosis factor receptor super family (TR6) suppresses LIGHT-mediated apoptosis
4. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator
5. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response
6. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer
7. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells
8. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes
9. Antibodies to TR2 (herpesvirus entry mediator); a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines
10. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation
11. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth
12. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT costimulatory pathway
13. d-specific TCR transgenic mice transplanted with allogenic hearts under the cover of a short-term rapamycin treatment
14. BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator
15. Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD 154)
16. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
17. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice
18. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease
19. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
20. The role of the CD28 receptor during T cell responses to antigen
21. CD28-B7 interactions in T-cell activation
22. The B7 and CD28 receptor families
23. The ups and downs of T cell costimulation
24. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
25. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gammaproduction
26. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
27. CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1
28. Induction of allograft tolerance in the absence of Fas-mediated apoptosis
29. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts
30. The ligands and receptors of the lymphotoxin system
31. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice
32. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice
33. IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice